Akari Therapeutics (AKTX) Goodwill (2024 - 2026)

Akari Therapeutics has disclosed Goodwill across 3 years of filings, most recently posting $8.4 million for Q1 2026.

• Goodwill for Q1 2026 came in at $8.4 million, changed 0.0% year-over-year; the trailing twelve-month figure through Mar 2026 was $8.4 million (changed 0.0% YoY), and the FY2025 annual result was $8.4 million, changed 0.36% from the prior year.
• Goodwill came in at $8.4 million for Q1 2026 at Akari Therapeutics, roughly flat from $8.4 million in the prior quarter.
• In the past five years, Goodwill ranged from a high of $8.4 million in Q1 2025 to a low of $8.4 million in Q4 2024.
• The 3-year median for Goodwill is $8.4 million (2025), against an average of $8.4 million.
• Across the five-year window, Goodwill gained 0.36% in 2025 and changed 0.0% in 2026, its largest moves.
• Akari Therapeutics' Goodwill stood at $8.4 million in 2024, then increased by 0.36% to $8.4 million in 2025, then changed by 0.0% to $8.4 million in 2026.
• The last three Goodwill figures came in at $8.4 million (Q1 2026), $8.4 million (Q4 2025), and $8.4 million (Q3 2025), per Business Quant data.